| SpectraBase Spectrum ID |
8ad1R6C9u4g |
| Name |
1,4-Di-(2-Fluorobenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
302.159454978 u |
| Formula |
C18H20F2N2 |
| InChI |
InChI=1S/C18H20F2N2/c19-17-7-3-1-5-15(17)13-21-9-11-22(12-10-21)14-16-6-2-4-8-18(16)20/h1-8H,9-14H2 |
| InChIKey |
QILXKEAVDMKETI-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
302.369 g/mol |
| Nominal Mass |
302 u |
| Quality |
996 |
| Retention Index |
2152 |
| SMILES |
C=1(C(=CC=CC1)F)CN1CCN(CC=2C(=CC=CC2)F)CC1 |
| SPLASH |
splash10-0a4i-1900000000-0631283a253661a36942 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(2-Fluorobenzyl)
1,4-bis(2-fluorobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011186 |
